Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023)